BRANDY PROTZ: Open Payments
NPI 1508445511 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 62 payments from 16 companies in 2025. Trend: 2023 $618 · 2024 $635 · 2025 $1,076
Food & beverage: $1,060Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $422 |
| Novo Nordisk Inc | 15 | $227 |
| Neos Therapeutics, LP | 3 | $64 |
| Corcept Therapeutics | 3 | $60 |
| Astellas Pharma US Inc | 2 | $35 |
| Abbott Laboratories | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
Products named: VRAYLAR, Ozempic, UBRELVY, Wegovy, Adzenys XR-ODT, Korlym, QULIPTA, Veozah.
Industry payments across IN — which companies pay providers there.
